Comparison of Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction With Versus Without Hyperuricemia or Gout

高尿酸血症 痛风 医学 射血分数保留的心力衰竭 内科学 危险系数 心力衰竭 心脏病学 尿酸 射血分数 置信区间
作者
Anthony P. Carnicelli,Robert Clare,Karen Chiswell,Barbara L. Lytle,Magnus K. Bjursell,Shira Perl,Karolina Sundell Andersson,Katarina Hedman,Neha J. Pagidipati,Sreekanth Vemulapalli,Matthew T. Roe,Robert J. Mentz
出处
期刊:American Journal of Cardiology [Elsevier BV]
卷期号:127: 64-72 被引量:8
标识
DOI:10.1016/j.amjcard.2020.04.026
摘要

Hyperuricemia and gout are common in patients with heart failure (HF) and are associated with poor outcomes. Data describing hyperuricemia and gout in patients with HF with preserved ejection fraction (HFpEF) are limited. We used data from the Duke University Health System to describe characteristics of patients with HFpEF and hyperuricemia (serum uric acid >6 mg/dl) or gout (gout diagnosis or gout medication within the previous year) and to explore associations with 5-year outcomes (death and hospitalization). We identified 7,004 patients in the Duke University Health System with a known diagnosis of HFpEF who underwent transthoracic echocardiography between January 1, 2005 and December 31, 2017. A total of 1,136 (16.2%) patients with HFpEF also had hyperuricemia or gout. Patients with HFpEF and hyperuricemia or gout had a greater co-morbidity burden, more echocardiographic findings of cardiac remodeling, and higher unadjusted rates of all-cause death, all-cause hospitalization, and HF hospitalization compared with those with HFpEF without hyperuricemia or gout. After multivariable adjustment, patients with HFpEF and hyperuricemia or gout had a significantly higher rates of first all-cause hospitalization (adjusted hazard ratio 1.10 [95% confidence interval 1.02 to 1.19]; p = 0.020) and recurrent all-cause hospitalization (associated rate ratio 1.13 [95% confidence interval 1.01 to 1.25]; p = 0.026). After adjustment, no significant differences in death or HF hospitalization were observed. In conclusion, patients with HFpEF and hyperuricemia or gout were found to have a higher burden of co-morbidities and a higher rate of all-cause hospitalization, even after multivariable adjustment, compared to patients with HFpEF without hyperuricemia or gout. Hyperuricemia and gout are common in patients with heart failure (HF) and are associated with poor outcomes. Data describing hyperuricemia and gout in patients with HF with preserved ejection fraction (HFpEF) are limited. We used data from the Duke University Health System to describe characteristics of patients with HFpEF and hyperuricemia (serum uric acid >6 mg/dl) or gout (gout diagnosis or gout medication within the previous year) and to explore associations with 5-year outcomes (death and hospitalization). We identified 7,004 patients in the Duke University Health System with a known diagnosis of HFpEF who underwent transthoracic echocardiography between January 1, 2005 and December 31, 2017. A total of 1,136 (16.2%) patients with HFpEF also had hyperuricemia or gout. Patients with HFpEF and hyperuricemia or gout had a greater co-morbidity burden, more echocardiographic findings of cardiac remodeling, and higher unadjusted rates of all-cause death, all-cause hospitalization, and HF hospitalization compared with those with HFpEF without hyperuricemia or gout. After multivariable adjustment, patients with HFpEF and hyperuricemia or gout had a significantly higher rates of first all-cause hospitalization (adjusted hazard ratio 1.10 [95% confidence interval 1.02 to 1.19]; p = 0.020) and recurrent all-cause hospitalization (associated rate ratio 1.13 [95% confidence interval 1.01 to 1.25]; p = 0.026). After adjustment, no significant differences in death or HF hospitalization were observed. In conclusion, patients with HFpEF and hyperuricemia or gout were found to have a higher burden of co-morbidities and a higher rate of all-cause hospitalization, even after multivariable adjustment, compared to patients with HFpEF without hyperuricemia or gout.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
普鲁卡因发布了新的文献求助10
4秒前
Liang完成签到,获得积分10
5秒前
爱思考的小笨笨完成签到,获得积分10
6秒前
123456完成签到 ,获得积分10
6秒前
小飞完成签到 ,获得积分10
7秒前
俞斐完成签到,获得积分10
8秒前
我超爱cs完成签到,获得积分10
8秒前
爱因斯坦那个和我一样的科学家完成签到,获得积分10
15秒前
彭a完成签到,获得积分10
15秒前
Migrol完成签到,获得积分10
16秒前
高兴的小完成签到,获得积分10
16秒前
蕉鲁诺蕉巴纳完成签到,获得积分0
18秒前
慕青应助普鲁卡因采纳,获得10
18秒前
御剑乘风来完成签到,获得积分10
18秒前
李牛牛完成签到,获得积分10
22秒前
等待的代容完成签到,获得积分10
24秒前
传奇3应助小南孩采纳,获得10
24秒前
尊敬飞丹完成签到,获得积分10
25秒前
27秒前
离岸完成签到,获得积分10
27秒前
tian完成签到,获得积分10
29秒前
普鲁卡因发布了新的文献求助10
31秒前
daijk完成签到,获得积分10
32秒前
34秒前
风趣的烨磊完成签到,获得积分10
37秒前
仝富贵完成签到,获得积分10
38秒前
小南孩发布了新的文献求助10
39秒前
奔铂儿钯完成签到,获得积分10
40秒前
跳跃山柳完成签到,获得积分10
42秒前
量子星尘发布了新的文献求助10
44秒前
小南孩完成签到,获得积分10
47秒前
脑洞疼应助普鲁卡因采纳,获得10
53秒前
zhaoyaoshi完成签到 ,获得积分10
53秒前
chiazy完成签到,获得积分10
54秒前
智慧金刚完成签到 ,获得积分10
54秒前
汉堡包应助科研通管家采纳,获得10
54秒前
科研通AI2S应助科研通管家采纳,获得10
54秒前
54秒前
迪鸣完成签到,获得积分0
56秒前
浪费青春传奇完成签到 ,获得积分10
59秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022